Mevacor and Osteopenia - a phase IV clinical study of FDA data

Summary:

Osteopenia is reported as a side effect among people who take Mevacor (lovastatin), especially for people who are female, 60+ old, also take Neurontin, and have High blood pressure.

The phase IV clinical study analyzes which people have Osteopenia when taking Mevacor. It is created by eHealthMe based on reports of 4,917 people who have side effects when taking Mevacor from the FDA, and is updated regularly.

What is Mevacor?

Mevacor has active ingredients of lovastatin. It is often used in high blood cholesterol. eHealthMe is studying from 4,988 Mevacor users. Check the latest studies of Mevacor.

What is Osteopenia?

Osteopenia (a condition where bone mineral density is lower than normal) is found to be associated with 1,438 drugs and 1,172 conditions by eHealthMe. Check the latest studies of Osteopenia.

On Aug, 04, 2026

4,917 people reported to have side effects when taking Mevacor.
Among them, 36 people (0.73%) have Osteopenia.

Among these 36 people:

What is the gender of people who have Osteopenia when taking Mevacor? *

female: 52.78 %
male: 47.22 %

What is the age of people who have Osteopenia when taking Mevacor? *

What are other drugs people take besides Mevacor? *

What are other side effects people have besides Osteopenia? *

Spinal Osteoarthritis (joint cartilage loss in spine): 22 people, 61.11%
Stress And Anxiety: 20 people, 55.56%
Pain In Jaw: 18 people, 50.00%
Fall: 17 people, 47.22%
Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery): 17 people, 47.22%
Osteonecrosis Of Jaw (death of bone of jaw): 16 people, 44.44%
Dyspnea (difficult or laboured breathing): 16 people, 44.44%
Acute Kidney Failure: 14 people, 38.89%
Pain: 14 people, 38.89%
Cellulitis (infection under the skin): 14 people, 38.89%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 10 people, 27.78%
High Blood Pressure: 10 people, 27.78%
Neoplasm Malignant (cancer tumour): 7 people, 19.44%
Menopausal Symptoms: 6 people, 16.67%
Type 2 Diabetes: 4 people, 11.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 11.11%
Adenoma Benign (non-cancerous tumour -secreting): 3 people, 8.33%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 3 people, 8.33%
Prostate Cancer: 2 people, 5.56%
Pain: 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Mevacor and have Osteopenia?

- Check whether Osteopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mevacor:

Mevacor (4,988 reports)

Osteopenia treatments and more:

Osteopenia (46,948 reports)

Browse all side effects of Mevacor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteopenia:

Osteopenia (1,438 drugs)

Browse all the conditions that are associated with Osteopenia:

Osteopenia (1,172 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lovastatin (the active ingredients of Mevacor) and Mevacor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.